Probiotic mixture VSL#3 reduce high fat diet induced vascular inflammation and atherosclerosis in ApoE−/− mice

The Probiotic VSL#3 Has Anti-inflammatory Effects and Could Reduce Endoscopic Recurrence After Surgery for Crohn's Disease

(2015) Richard N. Fedorak et al.   Clinical Gastroenterology and Hepatology

Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial

(2014) Radha K. Dhiman et al.   GASTROENTEROLOGY

Probiotic Mix VSL#3 Is Effective Adjunctive Therapy for Mild to Moderately Active Ulcerative Colitis

(2014) Houssam E. Mardini et al.   INFLAMMATORY BOWEL DISEASES

Lack of Association betweenABO,PPAP2B,ADAMST7,PIK3CG, andEDNRAand Carotid Intima-Media Thickness, Carotid Plaques, and Cardiovascular Disease in Patients with Rheumatoid Arthritis

(2014) Raquel López-Mejías et al.   MEDIATORS OF INFLAMMATION

VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation

(2012) Andrea Mencarelli et al.   PLoS One

Lactobacillus reuteri Prevents Diet-Induced Obesity, but not Atherosclerosis, in a Strain Dependent Fashion in Apoe−/− Mice

(2012) Frida Fåk et al.   PLoS One

Symptomatic atherosclerosis is associated with an altered gut metagenome

(2012) Fredrik H. Karlsson et al.   Nature Communications

Telmisartan Exerts Antiatherosclerotic Effects by Activating Peroxisome Proliferator-Activated Receptor-γ in Macrophages

(2011) Takeshi Matsumura et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effects of telmisartan and losartan on cardiovascular protection in Japanese hypertensive patients

(2011) Hiroshi Hasegawa et al.   HYPERTENSION RESEARCH

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

(2011) Zeneng Wang et al.   NATURE

Influence of consumption of probiotics on the plasma lipid profile: A meta-analysis of randomised controlled trials

(2011) Z. Guo et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Sedentary Behaviors Increase Risk of Cardiovascular Disease Mortality in Men

(2010) TATIANA Y. WARREN et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Gut Microbiota in Health and Disease

(2010) Inna Sekirov et al.   PHYSIOLOGICAL REVIEWS

Human oral, gut, and plaque microbiota in patients with atherosclerosis

(2010) O. Koren et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effect of Probiotics on Intestinal Barrier Function

(2009) Rudolf Mennigen et al.   Annals of the New York Academy of Sciences

Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: A randomized controlled trial

(2009) Caroline Karlsson et al.   ATHEROSCLEROSIS

Telmisartan Increases the Permeability of Endothelial Cells through Zonula Occludens-1

(2009) Chang Bian et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The Improvement of Hypertension by Probiotics: Effects on Cholesterol, Diabetes, Renin, and Phytoestrogens

(2009) Huey-Shi Lye et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The gut microbiota modulates host energy and lipid metabolism in mice

(2009) Vidya R. Velagapudi et al.   JOURNAL OF LIPID RESEARCH

Evaluating the glucose tolerance test in mice

(2008) Sofianos Andrikopoulos et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Anti-atherosclerotic properties of telmisartan in advanced atherosclerotic lesions in apolipoprotein E deficient mice

(2008) Erwin Blessing et al.   ATHEROSCLEROSIS

Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding

(2008) P.D. Cani et al.   PATHOLOGIE BIOLOGIE

Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults

(2008) Riina A Kekkonen et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL